UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii151

2018

Volltextzugriff (PDF)

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

ESMO open, 2022-06, Vol.7 (3), p.100427-100427, Article 100427

2022

Volltextzugriff (PDF)

Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome

Molecular oncology, 2022-10, Vol.16 (20), p.3620-3641

2022

Volltextzugriff (PDF)

Safety and Activity of Sorafenib in Addition to Vinflunine in Post‐Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial

The oncologist (Dayton, Ohio), 2019-06, Vol.24 (6), p.745-e213

2019

Volltextzugriff (PDF)

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

The lancet. Gastroenterology & hepatology, 2019-05, Vol.4 (5), p.376-388

2019

Volltextzugriff (PDF)

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Cancers, 2021, Vol.13 (11), p.2604

2021

Volltextzugriff (PDF)

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study

Journal of geriatric oncology, 2023-01, Vol.14 (1), p.101408-101408, Article 101408

2023

Volltextzugriff (PDF)

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5603

2022

Volltextzugriff (PDF)

Patients' perception of the ambulance services at Hospital Universiti Sains Malaysia

Singapore medical journal, 2008-08, Vol.49 (8), p.631-635

2008

Volltextzugriff (PDF)

Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Oncology letters, 2016-08, Vol.12 (2), p.1293-1300

2016

Volltextzugriff (PDF)

Vertex method for computing functions of fuzzy variables

Fuzzy sets and systems, 1987-10, Vol.24 (1), p.65-78

1987

Volltextzugriff (PDF)

Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma

Molecular oncology, 2016-05, Vol.10 (5), p.719-734

2016

Volltextzugriff (PDF)

Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma

Urologic oncology, 2014, Vol.32 (8), p.1215-1224

2014

Volltextzugriff (PDF)

Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient

Anti-cancer drugs, 2013-07, Vol.24 (6), p.648-652

2013

Volltextzugriff (PDF)

Management of advanced prostate cancer - new drugs

Acta oncologica, 2011-06, Vol.50 (S1), p.137-140

2011

Volltextzugriff (PDF)

Crystal structure of 1,3-dibenzyl-2-oxo-4,6-diphenyl-1,2,3,4-tetrahydropyridine- 3-carbonitrile, C32H26N2O

Zeitschrift für Kristallographie. New crystal structures, 2002-12, Vol.217 (1), p.29-31

2002

Volltextzugriff (PDF)

AMBULANCE RESPONSE TIME AND EMERGENCY MEDICAL DISPATCHER PROGRAM : A STUDY IN KELANTAN, MALAYSIA

Southeast Asian journal of tropical medicine and public health, 2008-11, Vol.39 (6), p.1150-1154

2008

Volltextzugriff (PDF)

Crystal structure of 2-(O,O-isopropyledene-2,3-dihydroxypropoxy)-3- cyano-4,6-diphenylpyridine, C24H22N2O3

Zeitschrift für Kristallographie. New crystal structures, 2002-12, Vol.217 (1), p.32-34

2002

Volltextzugriff (PDF)

Crystal structure of 2-(O,O-isopropyledene-2,3-dihydroxypropoxy)-3- cyano-4,6-diphenylpyridine, C24H22N2O3

Zeitschrift für Kristallographie. New crystal structures, 2002-12, Vol.217 (JG), p.32-34

2002

Volltextzugriff (PDF)

The presence of family during resuscitation in critical care settings: Nurses perspectives

Medical journal of Malaysia, 2024-03, Vol.79 (Suppl 1), p.67-73

2024

Volltextzugriff (PDF)

410P Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

Annals of oncology, 2022-09, Vol.33, p.S723

2022

Volltextzugriff (PDF)

345P The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

Annals of oncology, 2022-09, Vol.33, p.S694

2022

Volltextzugriff (PDF)

The effect of BRAF V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-studye

Journal of geriatric oncology, 2024, Vol.15 (2), p.101632

2024

Volltextzugriff (PDF)

455PDNORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

PCN202 - Prescription Pattern Of Opioids Among Prostate Cancer Patients Of Various Racial Groups

Value in health, 2018-05, Vol.21, p.S43-S43

2018

Volltextzugriff (PDF)

1 – 25 von 754

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(539)
Mit Volltextzugriff
(623)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(750)
Deutsch
(3)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome

Safety and Activity of Sorafenib in Addition to Vinflunine in Post‐Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

Patients' perception of the ambulance services at Hospital Universiti Sains Malaysia

Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Vertex method for computing functions of fuzzy variables

Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma

Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma

Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient

Management of advanced prostate cancer - new drugs

Crystal structure of 1,3-dibenzyl-2-oxo-4,6-diphenyl-1,2,3,4-tetrahydropyridine- 3-carbonitrile, C32H26N2O

AMBULANCE RESPONSE TIME AND EMERGENCY MEDICAL DISPATCHER PROGRAM : A STUDY IN KELANTAN, MALAYSIA

Crystal structure of 2-(O,O-isopropyledene-2,3-dihydroxypropoxy)-3- cyano-4,6-diphenylpyridine, C24H22N2O3

Crystal structure of 2-(O,O-isopropyledene-2,3-dihydroxypropoxy)-3- cyano-4,6-diphenylpyridine, C24H22N2O3

The presence of family during resuscitation in critical care settings: Nurses perspectives

410P Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

345P The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

The effect of BRAF V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-studye

455PDNORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

PCN202 - Prescription Pattern Of Opioids Among Prostate Cancer Patients Of Various Racial Groups

Suchergebnisse filtern